We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Hologic to Distribute Esaote MRI Systems

By HospiMedica staff writers
Posted on 04 Oct 2005
Hologic, Inc. More...
(Bedford, MA, USA) and Esaote (Genoa, Italy) have entered into an exclusive distribution and service agreement in the United States for extremity magnetic resonance imaging (MRI) systems manufactured by Esaote. The agreement is for an initial term of three years, with automatic one-year renewal options.

Under the terms of the agreement, Hologic will sell and service Esaote's line of extremity MRI systems, optimized for orthopedic and rheumatology imaging. Esaote's systems provide a compact alternative to full body MRI systems that require considerably higher expenditures and extensive build-outs. Extremity MRI systems also are designed to provide a more comfortable, less imposing patient experience as compared to full body
systems.

Esaote's MRI systems provide multiple applications including ultra-high resolution, small-joint assessment for rheumatology as well as open MRI for extremity and shoulder imaging in orthopedics. Hologic has an extensive sales network in the United States geared to the outpatient imaging market, predominantly in orthopedics and rheumatology through the sale of the company's x-ray bone density and Fluoroscan C-arm imaging systems.

"Dedicated MRI is a natural fit for our distribution and service channels, particularly in the in-office imaging segment,” commented Rob Cascella, president and COO of Hologic. "Esaote's long history of excellence and innovation in the area of extremity MRI is consistent with our goal of maintaining a leadership position in the segments we serve.”

"Hologic's reputation for service and product excellence were key factors in our decision to partner with them for the important U.S. market,” said Dr. Luigi Satragno, general manager of Esaote's MRI division. "Their long-term focus on the field of musculo-skeletal imaging, and their high levels of customer satisfaction were also essential in our decision to partner with Hologic.”

Hologic Inc. is a developer, manufacturer, and supplier of medical imaging systems dedicated to serving the healthcare needs of women, and a developer of digital imaging technology for general radiography and mammography applications. Esaote is a manufacturer of medical diagnostic equipment, including dedicated MRI systems, and is a major provider of ultrasound and information technology.



Related Links:
Hologic
Esaote

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Premium Air-Mattress
MA-51
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.